npat slightli expect bofaml con
highlight america strong devic mask sale
row cc strong devic sale cc across countri particularli
franc korea reimburs open last quarter
lowlight row mask cc lower expect bofaml cc
comment row lag america quietair uplift yet come
launch lose market share exclud healthcarefirst hcf
brightre achiev high singl digit growth lower doubl digit
expect confid brightre excl hcf achiev doubl digit
growth slight decreas averag sell price reflect geograph mix off-set
point plan acquisit us eur asia detail continu
grow home health hospic market astral upgrad mobi launch hcf acquisit
outlook remain posit provid headlin revenu ep
guidanc guidanc cost consist call make slight chang
reflect sale gross margin pre vest reflect
oper leverag achiev
remain bullish reiter buy rate slightli increas po
full definit iqmethod sm measur see page
employ non-u affili mlpf registered/qualifi research analyst
finra rule
refer import disclosur inform certain bofa merril lynch entiti take
respons report particular jurisdict
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
outsid equiti interest npat
chang work capit
 flow item int tax
 flow oper
oper
acquisit dispos invest
 flow invest
invest
 flow financ
financ
return capit employ
return equiti
iqmethod sm qualiti earn
full definit iqmethod sm measur see page
lead develop
manufactur medic devic mask cloud-
base softwar applic diagnos treat
manag respiratori disord headquart
san diego california focuss
connect health deliv better outcom
sleep apnea chronic obstruct pulmonari
outpac industri growth
market share place
everi market oper benefit
clinic data-captur proprietari
softwar boost therapi complianc
rate increas mask accessori growth
addit market develop
market activ target
moder sever osa suffer world-wide
price book valu
 revenue
sg revenue
tabl earn estim chang
 revenue
sg revenue
chang work cap
pv cash flow
pv termin valu
pv equiti
aud pv equiti
price object per share base dcf
valuat dcf use wacc termin growth rate beta
po would trade premium key competitor phia pe basi
think justifi given superior growth potenti
downsid risk po market educ effort achiev
expect revenu growth center medicar medicaid servic
propos chang us reimburs reimburs chang health
ministri phi technolog advanc competitor product fx
lyann harrison herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
